Lucid Diagnostics Inc (LUCD) Stock Price, Quote & News

Company Profile

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths t...

Industry: Medical Devices

Sector: Healthcare

Phone: 917 813 1828

Website: www.luciddx.com

Address:

360 Madison Avenue, 25th Floor, New York, United States

zoomlik Jul. 3 at 2:57 PM

$LUCD I recall Medicaire discussion back in 2022. It has been a while

0 · Reply

tds_ Jul. 2 at 9:49 PM

$LUCD I don't see EsoGuard/Lucid specifically mentioned except at the bottom of the firefighter story ("Content courtesy of Lucid Diagnostics"). But they are in pretty good company here... https://x.com/LucidDiag/status/2072778935931109394 https://www.acla.com/the-power-of-knowing/ https://www.acla.com/wp-content/uploads/2026/05/PoK-LucidDx-Story_Revised-05.26.pdf

0 · Reply

chuckjackson Jul. 2 at 9:01 PM

$LUCD $PAVM as I mentioned before, it looks like moidx handles draft lcds in batches and there is a seasonality. They haven't historically issued drafts on a weekly basis throughout the year. Last year, two were issued on 7/9/25 and three were issued on 8/18/25. If we miss this batch, we may have to wait another half year for the next batch. The "good" news is that it will be likely that they will be actually issuing draft lcds in the coming weeks (unlike the last several weeks when there was practically no chance). No guarantee that they will issue the draft for lucd but there is a chance that it will happen. The 7/9/25 appeared on the 7/13/25 update. The 8/18/25 appeared on the 8/23/25. The exact dates seem to vary each year but we are approaching draft lcd season

0 · Reply

minnesotafarmcountry Jul. 2 at 7:04 PM

$LUCD Hey … at least it’s not volatile 😂

0 · Reply

PortfolioMgmt23 Jul. 2 at 6:40 PM

$LUCD Anyone else find this calm stable pricing action kind of remarkable given that there was no news today? I do.

2 · Reply

crypto_biotech Jul. 2 at 5:55 PM

$LUCD Should look different by EOY despite trash management.

0 · Reply

crypto_biotech Jul. 2 at 3:52 PM

$LUCD Sold relatively large position yesterday and today , but keeping some. Most went to $UNCY & $ARDX I do not believe we will get anything before EOY. If so will get back in. Management is hideous. More dilution and they have zero credibility for approval timeline or MOIDX They will eventually get it approved and then most here will do well. At this point it’s opportunity cost. I am only here to make money and being as transparent as possible. The scumbags said imminent over 1 year ago.

3 · Reply

minnesotafarmcountry Jul. 2 at 3:35 PM

$LUCD It’s as if the market knows it’s coming … otherwise we’d sell off. Instead, steady accumulation 👍🏻 Happy 250th birthday 🇺🇸💥

0 · Reply

PortfolioMgmt23 Jul. 2 at 2:41 PM

$LUCD I've done my due diligence. I still believe we have the best device in EsoGuard and EsoCheck to save lives through early detection. I hate that we're going to be 10 months out from our CAC without word after recieving such resounding support from the medical community. I'm nervous, not going to lie. But I still believe those things and I have to believe we're getting this draft LCD in July. This process should have taken 6 to 9 months. We're now at 10. Here's to a perfect 10 draft LCD in July. I've researched, watched and prayed. Nothing left to do now.

2 · Reply

JRINPHX Jul. 2 at 1:42 PM

$LUCD- Meanwhile at the beach… https://www.linkedin.com/posts/earlydetection-ugcPost-7476380583162679296-1HIg/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAAALVRjkBicv7E6AjpBDq6WibNH_8nRDbrZs&utm_campaign=share_via

1 · Reply

Lucid Diagnostics Transcript: AGM 2026

Jun 12, 2026, 7:00 AM EDT - 22 days ago

Lucid Diagnostics Slides: Investor presentation

2026-05-15T15:26:45.000Z - 7 weeks ago

Lucid Diagnostics price target lowered to $2 from $3 at Maxim

May 15, 2026, 8:00 AM EDT - 7 weeks ago

Market Cap	217.28M
Revenue (ttm)	4.71M
Net Income (ttm)	-58.01M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,231.63%
Debt to Equity Ratio	6.30

Volume	791,700
Avg Vol	1,264,734
Day's Range	N/A - N/A
Shares Out	203.07M
Stochastic %K	65%
Beta	1.07
Analysts	Strong Sell
Price Target	$3.95